
Global cancer immunotherapy market to be valued at $247.2b by 2029
Developments in genomics, AI, and biotechnology are driving market growth.
The global cancer immunotherapy market is projected to reach $247.2b by 2029 at a compound annual growth rate of 11.4%, said BCC Research.
The sector’s expansion is attributed to the rising prevalence of cancer, approvals of immunotherapy drugs, and increased government funding and pharmaceutical research and development spending.
Moreover, developments in genomics, artificial intelligence, and biotechnology are driving market growth.
By technology, checkpoint inhibitors are expected to dominate throughout the forecast period.